Overall performance of the indian pharmaceuticals industry

April 2007
Drugs and Pharmaceuticals
Industry Highlights
Contents
Chapter Page
− US congress considers new bill for generic drugs − Drug discovery and development: An Indian − Merck cuts anti-aids drug price − Climate change to hit the pharmaceutical News & Views
− Merck cuts price of once daily HIV drug Industry News 5
− Indonesia agrees to share flu virus sample with − Pharma industry mixed reaction to budget − NPIL to invest $50 mn in new facilities − Ranbaxy gets regulatory nod in Romania Healthcare News
Pharma sector sets for double digit growth Health sector gets Rs. 15,291 crore in budget Domestic pharma firms perform well in third − Nutraceuticals market in India to grow − Alkem healths plan Rs 25 cr investment − Government focuses on polio eradication in − 11 cases of polio detected this year − World population will reach 9.2 billion by 2050 − Glenmark’s Argentina subsidiary gives positive − Neurological disorders affect millions globally: − Canada & Gates foundation launches new HIV Regulatory News
− WHO reports some promising results on avian − Budget proposals announced for 2007-08 Product News
Global News
− Cipla enters agreement with DNDi for anti- Industry Highlights, April 2007
April 2007
− Govt. unlikely to accept Mashelkar view on − Ethypharm in licensing deal with Shantha − Indian laws does not comply with IPR: Novartis − Glaxo new cancer drug gets USFDA approval − Rejecting patents on chemical derivatives − Ranbaxy targets US for $2b sales from generic − EU, US shows concern over public health − Ranbaxy arm gets nod for 20 products − Indian patents act does not violate trips, govt − DCGI approves Bentley’s nasulin trial in India − Strides Arcolab gets US FDA nod for ARV − Ranbaxy suit in US for delay in launch of − Merck & Co’s new HIV treatment shows − Pfizer challenges Ranbaxy against Caduet − Pharma claims 10.4% of all worldwide patent − Sanofi-Aventis to launch fixed dose anti- − US patent office rejects Genetech’s Cabilly II − Indian drug cos focus on new molecules − Pfizer sues Ranbaxy on patent infringement R&D News
− Glanmark in pact with Dyax for research Parliament News
− GVK Bio enters into JV with INC research Lok Sabha
− Novozymes to set up R&D centre in Bangalore − Nicholas Piramal to invest $50m in contract − R&D proposals signed at Bio-Asia 2007 − Regulatory delay hit clinical research firms − Polio cases − Aswagandha for treatment of HIV/AIDS Biotechnology
Indian biotech sector achieves 35% growth − Biocon subsidiary enters R&D pact with Rajya Sabha
− Biotech firms mixed reactions on budget − Biocon to invest rs. 1000 cr. in Andhra Pradesh − Measures taken for surveillance of leprosy − Geovax’s HIV vaccine shows promise in phase − National plan for advanced TB control − First recombinant polyclonal antibody enter − US promotes biogenerics introduction − Recent Indian patents in the field of drugs & Views expressed in the journal are those of the authors and the Editorial Board/Publisher takes no responsibility for the same. We are a secondary abstracting service and the veracity of information is of the source quoted and not our primary responsibility. Industry Highlights, April 2007

Source: http://cdriindia.org/I42007contentpage.pdf